For the tumor in H22 liver cancer mouse model, there was 33.19% (P = 0.0314) or 43.04% (P = 0.0079) inhibition by single-drug therapy of PD-1 or L.p R3, meanwhile, the inhibition was 70.75% (P = 0. This evidence concerns the gene PDCD1 and liver cancer.